External Causes of Death More Likely in Those With Bipolar Disorder
While bipolar disorder is known to be associated with early mortality, deaths…
Browsing Tag
bipolar
Bipolar Depression Market to Exhibit Positive Growth by 2032, Predicts DelveInsight |…
New York, USA, July 03, 2023 (GLOBE NEWSWIRE) -- Bipolar Depression Market to Exhibit Positive Growth by 2032, Predicts DelveInsight | Key Companies to Watch Out - NeuroRx, SAGE, Janssen,…
Link Between Early Bipolar Diagnosis and Lower Suicide Rates Identified
underlies roughly five percent of all suicides among young people. Previous studies also show that there is often a long delay between the onset of bipolarism and its correct diagnosis and…
A gate driver for circuit bipolar transistor electronic switches
Credit: CC0 Public Domain
Many homes have electronic timers for automatically turning…
Hearing about bipolar disorder in the news or on social media? Here’s what you should…
In the news or on social media, we hear the term “bipolar disorder” a lot.Whether it’s celebrities opening up about their diagnoses or an investigation finding that a person has struggled…
Unraveling auger recombination in bipolar devices under high carrier injection
A depiction of the N dependence of Auger recombination rate for n-type layers with film thickness of 150 μm (T-150)…
FDA OKs Vraylar for Depression; Schizophrenia Fingerprint? Fanapt Works in Bipolar
The FDA has approved AbbVie's cariprazine (Vraylar) as an adjunctive treatment for major…
Smartphone App May Be Beneficial for Some With Bipolar Disorder
Elana Gotkine
WEDNESDAY, Dec. 21, 2022 (HealthDay News) -- A smartphone-based self-management app does not reduce the risk of relapse among patients…
Managing Agitation in Bipolar Disorder, Schizophrenia
During the 2022 Neuroscience Education Institute (NEI) Congress, Leslie Citrome, MD, MPH, clinical…
COMP360 psilocybin therapy shows potential in open-label study in type II bipolar…
12 out of 14 patients went into remission for three months following a single 25mg dose of COMP360 psilocybin therapy, in an independent investigator-initiated, exploratory open-label study…